In this section
The Respiratory group comprises a multi-disciplinary team of dynamic, friendly and committed clinicians and researchers working together on a program of clinical, laboratory and epidemiological research. This group focuses on generating high quality
research with ambitious research and clinical outcomes through collaborations with The Royal Children’s Hospital and a number of institutions nationally and overseas.
Several areas of research undertaken within this group relate to common chronic childhood respiratory conditions such as asthma, cystic fibrosis, long-term effects of prematurity, allergy and tuberculosis. The group is also responsible for a large, long-standing epidemiology asthma project (MESCA) which is a unique
resource and is well respected internationally for the insight provided by the study into the development and evolution of childhood asthma.
The main research focus of this group is in the assessment, treatment and prevention of cystic fibrosis lung disease in young children. We believe that by preventing lung disease early in life, individuals with cystic fibrosis will live longer fulfilling lives. The Early Surveillance Program (AREST CF) is a
collaboration of specialist pediatric fibrosis centers in Perth and Melbourne, in conjunction with teams in Chapel Hill, North Carolina, Indianapolis, Indiana, St Louis, Washington and Rotterdam, Netherlands, who work together to improve the respiratory health and outcomes of children with cystic fibrosis.
ARSET CF is internationally recognized for its world leading research in this area.
For more information relating to the specific types of research currently undertaken by the department, please use the following links:
Cystic Fibrosis Research Funding Application